Cipla Launches ‘Covi-G', A Rapid Antibody Test Kit For Covid-19
Dalal Street Investment Journal|November 23, 2020
Global pharmaceutical company, Cipla Limited announced that it has signed a licensing agreement with Multi G, a Belgium-based company for distribution of its Rapid Antibody test kit for COVID-19.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM DALAL STREET INVESTMENT JOURNALView All

The Art Of Asset Allocation

Mutual Fund Distributor

3 mins read
Dalal Street Investment Journal
January 04, 2021

George Joseph CEO and CIO, ITI Mutual Fund

In this exclusive interview, George Joseph, CEO and CIO, ITI Mutual Fund, expresses his opinion about the status of the MF sector in the new scenario post the pandemic and how his fund house is strategizing future investments

5 mins read
Dalal Street Investment Journal
January 04, 2021

LUX INDUSTRIES IN A ‘COMFORTABLE' POSITION

Some of the strengths of Lux Industries include rich sectoral experience, extensive distribution network, substantial cost leadership, proprietary manufacturing ability, vast product variety and sharp focus on the mid-price segment

5 mins read
Dalal Street Investment Journal
January 04, 2021

Turnaround Companies Of 2020

The year 2020 was anything but dull for equity investors. Many made money in 2020 and on an average the risk-taking appetite was on the rise in 2020. The stock prices were no doubt volatile and several stocks more than doubled in 2020. The year clearly belonged to the defensives and penny stocks and to a great extent 2020 was also a year for turnaround stocks. Shreya Chaware highlights the turnaround stories that helped create wealth for investors in 2020 while also sharing key elements to watch out for in identifying turnaround stocks

6 mins read
Dalal Street Investment Journal
January 04, 2021

Welcome 2021 With A Revisited Portfolio

Hemant Rustagi Chief Executive Officer, Wiseinvest Pvt Ltd.

3 mins read
Dalal Street Investment Journal
January 04, 2021

Replace Fixed Deposits With Mutual Fund Schemes

The worst hit by the lower interest rates are investors who had relied on bank fixed deposits to earn interest. The option for such investors is to shift to debt mutual funds. The article explains why

4 mins read
Dalal Street Investment Journal
January 04, 2021

Markets End 2020 On A Cheery Note

With positive news announcements about the vaccines and successful clinical trials, the healthcare industry remained in the limelight, gaining 2.10 per cent during the fortnight

4 mins read
Dalal Street Investment Journal
January 04, 2021

ALKEM LABORATORIES ON A ‘PRESCRIBED' JOURNEY OF SUCCESS

Alkem Laboratories Limited is a pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products.

2 mins read
Dalal Street Investment Journal
January 04, 2021

Jayesh Dadia Chartered Accountant

Tax Column

4 mins read
Dalal Street Investment Journal
January 04, 2021

2021 Value Stocks

Market participants are focusing on 2021 and there is a huge level of enthusiasm and high expectation on the part of investors as far as the forthcoming year goes after an unbelievable 2020. It was not easy to pick pharmaceutical and IT as probable winners at the start of 2020 and similarly it will not be easy to pick the set of stocks that may dominate in 2021. Geyatee Deshpande puts forth a case for value stocks to do well in 2021 while Yogesh Supekar highlights how to identify value stocks

10+ mins read
Dalal Street Investment Journal
January 04, 2021
RELATED STORIES

“We have 18 international patents granted for Stempeucel pooling technology”

Bengaluru based Stempeutics Research has received regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel in India.

5 mins read
Bio Spectrum
November 2020

INDIAN PHARMA PRODUCING COVID - 19 DRUGS FOR MASSES

Known for its expertise in manufacturing and supplying quality generic drugs, Indian pharma sector is currently using the generic tool as a critical arsenal in the fight against COVID–19. At present, there are around 25 different drugs brands available in the Indian market to treat the COVID-19 patients, with many more in the pipeline.

10+ mins read
BioSpectrum Asia
BioSpectrum Asia September 2020

INDIA: DESERVES TO BE THE WORLD'S NEW MANUFACTURING HUB

In view of the recent ecological and geopolitical developments in the world, there is a strong quest for world’s new manufacturing hub. This article makes an attempt to discuss the strong claim of India for this position because of its political, economical, geographical and legal edges. This article concludes with opportunity available to India and the need of policy makers to encash the same.

10+ mins read
The Management Accountant
August 2020

Launched by Servotec: Digital Sanitizer on Your Smart Phone

The outbreak of novel Corona Virus has entirely changed the way humans used to live. Five months back nobody would have even dreamt of seeing human beings wearing masks, face shields and carrying sanitizers with them but now these things have become an essential part of a man's life. Our lives have a new normal as we begin live with the pandemic.

3 mins read
SME World
August 2020

MAKING OUT OF INDIA

Pharmaceutical players will set up plants in major markets, go for more automation and focus on digital marketing

7 mins read
Business Today
May 31, 2020

Finding The Silver Lining Of Coronavirus Pandemic

As India Pharma Inc reels under the far-reaching impact of the coronavirus epidemic, industry experts suggest policy reforms to insulate the sector and improve its emergency-preparedness

10+ mins read
Express Pharma
March 16-31, 2020

CELEBRATING WOMANHOOD ON EQUAL NOTE

As nations around the world celebrate International Women’s Day on March 8, with the theme #EachforEqual, the number of companies that have had women in a leadership role continues to expand. But the list is still relatively short, and even when women have made it to power, they have rarely led for a long time. Globally women at leadership position are very less and only 4.9 per cent of Fortune 500 companies have women at leadership position.

10+ mins read
BioSpectrum Asia
March 2020

BREATH OF NEW AIR

Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in respiratory medicine, readiness for a crusade against antibiotic resistance, and vision for relevance beyond pharma.

9 mins read
Fortune India
December 15, 2019 - March 14, 2020

The Pharma Wonderkid

Seventeen-year-old Arjun Deshpande is on a mission to ensure generic medicines reach India’s masses at affordable rates

4 mins read
Forbes India
December 20, 2019

Scrutiny Alarm For Indian Pharma Companies

It is time for Indian pharma companies to brace for heightened scrutiny as the US drug regulator ups the ante on standards.  

5 mins read
Business Today
March 13, 2016